A 10-YEAR SURVEY OF DERMATOMYCOSES IN UBERABA, SOUTHEAST BRAZIL
DOI:
https://doi.org/10.18554/acbiobras.v7i2.7965Palavras-chave:
superficial mycoses, dermatophytes, epidemiology, superficial candidiasis, non-dermatophyte filamentous fungiResumo
Superficial fungal infections, known as dermatomycoses, are among the main dermatological pathologies and affect approximately 25% of the world’s population. Knowing the epidemiology and promoting the diagnosis of these mycoses is essential for proper treatment administration. A total of 2,325 skin, nail and hair samples were collected from all patients treated at a private clinical laboratory in the city of Uberaba - Minas Gerais - with clinical suspicion of dermatomycosis between August 2012 and July 2022 and identified using classical methodology and the VITEK®2 YST ID system. Of the collected samples, 1,327 (57.10%) were positive for fungi, of which the majority were nail samples (61.64%), followed by skin samples from the feet (14.92%) and body (11.75%). Of these, the majority were from patients between the ages of 31 and 40 years (18.23%), and the majority of scalp samples were obtained from patients up to 10 years of age (91.66%). The most frequent fungi were dermatophytes (48.61%), followed by yeasts (28.79%) and non-dermatophyte filamentous fungi (NDFF) (22.61%), and the most common species were Trichophyton rubrum (41.22%), Candida parapsilosis (13.34%), Candida albicans (7.69%) and Aspergillus sp. (6.63%). The data herein corroborate the results of the majority of studies found in the literature and highlight the importance of knowing the prevalence of the etiological agents of these mycoses so that the correct treatment can be administered and, consequently, cases of empirical prescription, recurrence and antifungal resistance can be avoided.
Referências
Gunaydin SD, Arikan-Akdagli S, Akova M. Fungal infections of the skin and soft tissue. Curr Opin Infect Dis. 2020; 33(2):130-136. https://doi.org/10.1097/QCO.0000000000000630.
Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008; 51(Suppl4):2-15. https://doi.org/10.1111/j.1439-0507.2008.01606.x.
Zhan P, Liu W. The changing face of dermatophytic infections worldwide. Mycopathologia. 2017; 182(1-2):77-86. https://doi.org/10.1007/s11046-016-0082-8.
Heidrich D, Stopiglia CDO, Magagnin CM, Daboit TC, Vettorato G, Amaro TG, Scroferneker ML. Sixteen years of dermatomycosis caused by Candida spp. in the metropolitan area of Porto Alegre, southern Brazil. Rev Inst Med Trop Sao Paulo. 2016; 58:14. https://doi.org/10.1590/S1678-9946201658014.
Narang T, Bhattacharjee R, Singh S, Jha K, Kavita, Mahajan R, Dogra S. Quality of life and psychological morbidity in patients with superficial cutaneous dermatophytosis. Mycoses. 2019; 62(8):680-685. https://doi.org/10.1111/myc.12930.
Patel VM, Schwartz RA, Lambert WC. Topical antiviral and antifungal medications in pregnancy: a review of safety profifiles. J Eur Acad Dermatol. 2017; 31:1440-1446. https://doi.org/10.1111/jdv.14297.
Benedict K, Gold JAW, Wu K, Lipner SR. High Frequency of Self-Diagnosis and Self-Treatment in a Nationally Representative Survey about Superficial Fungal Infections in Adults-United States, 2022. J Fungi (Basel). 2022; 9(1):19. https://doi.org/10.3390/jof9010019.
Hay RJ. The Spread of Resistant Tinea and the ingredients of a perfect storm dermatology. Dermatology. 2022; 238(1):80-81. https://doi.org/10.1159/000515291.
Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017; 17:383-392. https://doi.org/10.1016/S1473-3099(17)30316-X.
Gupta AK, Venkataraman M. Antifungal resistance in superficial mycoses. J Dermatolog Treat. 2022; 33(4):1888-1895. https://doi.org/10.1080/09546634.2021.1942421.
ANVISA, Agência Nacional de Vigilância Sanitária - Microbiologia Clínica para o Controle de Infecção Relacionada à Assistência à Saúde. Módulo 8: Detecção e identificação de fungos de importância médica; 2013.
Köhler JR, Hube B, Puccia R, Casadevall A, Perfect JR. Fungi that infect humans. Microbiol Spectr. 2017; 5(3). https://doi.org/10.1128/microbiolspec.FUNK-0014-2016.
Charles AJ. Superficial cutaneous fungal infections in tropical countries. Dermatol Ther. 2009; 22(6):550-9. https://doi.org/10.1111/j.1529-8019.2009.01276.x.
Vallabhaneni S, Mody RK, Walker T, Chiller T. The Global Burden of Fungal Diseases. Infect Dis Clin North Am. 2016; 30(1):1-11. https://doi.org/10.1016/j.idc.2015.10.004.
Nweze EI, Eke IE. Dermatophytes and dermatophytosis in the eastern and southern parts of Africa. Med Mycol. 2018; 56(1):13-28. https://doi.org/10.1093/mmy/myx025.
Silva LB, Oliveira DBC, Silva BV, Souza RA, Silva PR, Ferreira-Paim K, Andrade-Silva LE, Silva-Vergara ML, Andrade AA. Identification and antifungal susceptibility of fungi isolated from dermatomycoses. J Eur Acad Dermatol Venereol. 2014; 28(5):633-640. https://doi.org/10.1111/jdv.12151.
Kovitwanichkanont T, Chong AH. Superficial fungal infections. Aust J Gen Pract. 2019; 48(10):706-711. https://doi.org/10.31128/AJGP-05-19-4930.
Pereira FO, Gomes SM, Silva SL, Teixeira APC, Lima IO. The prevalence of dermatophytoses in Brazil: a systematic review. J Med Microbiol. 2021; 70(3). https://doi.org/10.1099/jmm.0.001321.
Nowicka D, Nawrot U. Tinea pedis – An embarrassing problem for health and beauty - A narrative review. Mycoses. 2021; 64(10):1140-1150. https://doi.org/10.1111/myc.13340.
Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, Piraccini BM. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020; 34(9):1972-1990. https://doi.org/10.1111/jdv.16394.
Gupta AK, Venkataraman M, Shear NH, Piguet V. Onychomycosis in children - review on treatment and management strategies. J Dermatolog Treat. 2022; 33(3):1213-1224. https://doi.org/10.1080/09546634.2020.1810607.
Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology and treatment. J Cutan Med Surg. 2017; 21(6):525-539. https://doi.org/10.1177/1203475417716362.
Chen XQ, Yu J. Global Demographic Characteristics and Pathogen Spectrum of Tinea Capitis. Mycopathologia. 2023; 188(5):433-447. https://doi.org/10.1007/s11046-023-00710-8.
Leung AKC, Hon KL, Leong KF, Barankin B, Lam JM. Tinea capitis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020; 14(1):58-68. https://doi.org/10.2174/1872213X14666200106145624.
Menu E, Filori Q, Dufour JC, Ranque S, L'Ollivier C. A Repertoire of Clinical Non-Dermatophytes Moulds. J Fungi (Basel). 2023; 9(4):433. https://doi.org/10.3390/jof9040433.
Moreno G, Arenas R. Other fungi causing onychomycosis. Clin Dermatol. 2010; 28(2):160-163. https://doi.org/10.1016/j.clindermatol.2009.12.009.
Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol. 2012; 66(3):494-502. https://doi.org/10.1016/j.jaad.2011.02.038.
Guégan S, Lanternier F, Rouzaud C, Dupin N, Lortholary O. Fungal skin and soft tissue infections. Curr Opin Infect Dis. 2016; 29(2):124-130. https://doi.org/10.1097/QCO.0000000000000252.
Lipner SR, Scher RK. Onychomycosis – a small step for quality of care. Curr Med Res Opin. 2016; 32(5):865-867. https://doi.org/10.1185/03007995.2016.1147026.
Jaishi VL, Parajuli R, Dahal P, Maharjan R. Prevalence and risk factors of superficial fungal infection among patients attending a tertiary care hospital in central Nepal. Interdiscip Perspect Infect Dis. 2022; 3088681. https://doi.org/10.1155/2022/3088681.
Bayona JVM, García CS, Palop NT, Cardona CG. Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples. Diagn Microbiol Infect Dis. 2020; 98(4):115168. https://doi.org/10.1016/j.diagmicrobio.2020.115168.
Singh PD, Verma KR, Sarswat S, Saraswat S. Non-Candida albicans Candida Species: Virulence Factors and Species Identification in India. Curr Med Mycol. 2021; 7(2):8-13. https://doi.org/10.18502/cmm.7.2.7032.
Heckler I, Sabalza M, Bojmehrani A, Venkataraman I, Thompson C. The need for fast and accurate detection of dermatomycosis. Med Mycol. 2023; 61(5):myad037. https://doi.org/10.1093/mmy/myad037.
Mikailov A, Cohen J, Joyce C, Mostaghimi A. Cost-effectiveness of confirmatory testing before treatment of onychomycosis. JAMA Dermatol. 2016; 152(3):276-281. https://doi.org/10.1001/jamadermatol.2015.4190.
Gold JAW, Benedict K, Dulski TM, Lipner SR. Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States. J Am Acad Dermatol. 2023; 15:S0190-9622(23)00189-5. https://doi.org/10.1016/j.jaad.2023.02.009.
Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E, Gould C, Gemmen E, Dall T. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for investigative dermatology. J Am Acad Dermatol. 2006; 55:490-500. https://doi.org/10.1016/j.jaad.2006.05.048.
Schaller M, Friedrich M, Papini M, Pujol RM, Veraldi S. Topical antifungal-corticosteroid combination therapy for the treatment of superficial mycoses: conclusions of an expert panel meeting. Mycoses. 2016; 59(6):365-373. https://doi.org/10.1111/myc.12481.
Madarasingha NP. Evaluation of practice patterns of general practitioners and dermatologists in treating naive and recalcitrant dermatophytosis – an online survey. Sri Lanka J Dermatol. 2020; 21:10-16. https://slcd.lk/assets/img/member-info/journals/volume-21/sljod-v21-p10-16.pdf.
Verma SB, Zouboulis C. Indian irrational skin creams and steroid-modifified dermatophytosis - an unholy nexus and alarming situation. J Eur Acad Dermatol Venereol. 2018; 32:e426-7. https://doi.org/10.1111/jdv.15025.
Becker P, Lecerf P, Claereboudt J, Devleesschauwer B, Packeu A, Hendrickx M. Superficial mycoses in Belgium: Burden, costs and antifungal drugs consumption. Mycoses. 2020; 63(5):500-508. https://doi.org/10.1111/myc.13063.
